Legend Biotech (LEGN) Common Equity (2019 - 2025)
Legend Biotech (LEGN) posted Common Equity of $1.0 billion for Q4 2025, down 0.91% on a QoQ basis from $1.0 billion in Q3 2025, and down 3.7% year-over-year from $1.0 billion in Q4 2024.
Legend Biotech (LEGN) has 7 years of Common Equity data on file, last reported at $1.0 billion in Q4 2025.
- In Q4 2025, Common Equity fell 3.7% year-over-year to $1.0 billion; the TTM figure through Dec 2025 stood at $1.0 billion (down 3.7% YoY), while the FY2025 annual figure was $1.0 billion, down 3.7% from the prior year.
- Common Equity declined to $1.0 billion in Q4 2025, from $1.0 billion in the prior quarter.
- Across five years, Common Equity topped out at $1.4 billion in Q2 2023 and bottomed at $206451.0 in Q1 2021.
- A 5-year average of $870.9 million and a median of $1.0 billion in 2025 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity jumped 358900.44% — and 2024, when it decreased 17.63%.
- Year by year, Common Equity stood at $765.9 million in 2021, then declined by 2.82% to $744.3 million in 2022, then jumped by 68.12% to $1.3 billion in 2023, then dropped by 16.84% to $1.0 billion in 2024, then fell by 3.7% to $1.0 billion in 2025.
- The last three Common Equity figures came in at $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.34 Bn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 653.16 Mn |
| Dec 31, 2022 | 744.31 Mn |
| Mar 31, 2022 | 741.16 Mn |
| Dec 31, 2021 | 765.94 Mn |
| Sep 30, 2021 | 225.87 Mn |
| Jun 30, 2021 | 339,919.00 |
| Mar 31, 2021 | 206,451.00 |
| Dec 31, 2020 | 597.77 Mn |
| Sep 30, 2020 | 334,900.00 |
| Jun 30, 2020 | 401,001.00 |
| Dec 31, 2019 | 151.32 Mn |